{"entity":{"type":"insider","cik":"0001490283","url":"/insider/0001490283","json_url":"/insider/0001490283.json","name":"Young Richard A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":25,"first":"2012-03-16","last":"2026-08-05","span_basis":"filed_date"},"name_variants":[{"name":"Young Richard A","source":"filing","n_filings":25,"first_seen":"2012-03-16","last_seen":"2026-08-05"}],"transactions":[{"id":6097441,"accession":"0001628280-26-053513","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-053513","line_url":"/filing/0001628280-26-053513#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Camp4 Therapeutics Corp","issuer_ticker":"CAMP","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16378.0,"shares_display":"16,378","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":27023.7,"total_display":"27,023.70","shares_owned_after":186388.0,"shares_owned_after_display":"186,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-03","filed_date":"2026-08-05","scope":"insider"},{"id":4178488,"accession":"0001490283-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001490283-25-000003","line_url":"/filing/0001490283-25-000003#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Camp4 Therapeutics Corp","issuer_ticker":"CAMP","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15151.0,"shares_display":"15,151","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":24999.15,"total_display":"24,999.15","shares_owned_after":170010.0,"shares_owned_after_display":"170,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-11","filed_date":"2025-09-11","scope":"insider"},{"id":2117154,"accession":"0000950170-24-080480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-080480","line_url":"/filing/0000950170-24-080480#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34837.0,"shares_display":"34,837","price_per_share":5.12,"price_display":"5.12","price_state":"stated","total_value":178365.44,"total_display":"178,365.44","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-28","filed_date":"2024-07-02","scope":"insider"},{"id":8620259,"accession":"0000899243-23-014449","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-014449","line_url":"/filing/0000899243-23-014449#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Omega Therapeutics, Inc.","issuer_ticker":"OMGA","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":40000.0,"total_display":"40,000.00","shares_owned_after":739118.0,"shares_owned_after_display":"739,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-02","filed_date":"2023-06-05","scope":"insider"},{"id":7961903,"accession":"0000899243-23-012077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-012077","line_url":"/filing/0000899243-23-012077#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Omega Therapeutics, Inc.","issuer_ticker":"OMGA","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":40000.0,"total_display":"40,000.00","shares_owned_after":744118.0,"shares_owned_after_display":"744,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-01","filed_date":"2023-05-03","scope":"insider"},{"id":8010323,"accession":"0000899243-23-011034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-011034","line_url":"/filing/0000899243-23-011034#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Omega Therapeutics, Inc.","issuer_ticker":"OMGA","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":40000.0,"total_display":"40,000.00","shares_owned_after":749118.0,"shares_owned_after_display":"749,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-06","filed_date":"2023-04-10","scope":"insider"},{"id":8309657,"accession":"0000899243-23-009094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-009094","line_url":"/filing/0000899243-23-009094#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Omega Therapeutics, Inc.","issuer_ticker":"OMGA","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":80000.0,"total_display":"80,000.00","shares_owned_after":754118.0,"shares_owned_after_display":"754,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-20","scope":"insider"},{"id":8568832,"accession":"0000899243-23-001594","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-001594","line_url":"/filing/0000899243-23-001594#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Omega Therapeutics, Inc.","issuer_ticker":"OMGA","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":160000.0,"total_display":"160,000.00","shares_owned_after":764118.0,"shares_owned_after_display":"764,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-11","scope":"insider"},{"id":6620661,"accession":"0000899243-22-031138","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-031138","line_url":"/filing/0000899243-22-031138#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Omega Therapeutics, Inc.","issuer_ticker":"OMGA","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":80000.0,"total_display":"80,000.00","shares_owned_after":784118.0,"shares_owned_after_display":"784,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-14","filed_date":"2022-09-15","scope":"insider"},{"id":5035859,"accession":"0001209191-21-011992","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-011992","line_url":"/filing/0001209191-21-011992#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":12.05,"price_display":"12.05","price_state":"stated","total_value":45187.5,"total_display":"45,187.50","shares_owned_after":321711.0,"shares_owned_after_display":"321,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":5393852,"accession":"0001209191-21-009341","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-009341","line_url":"/filing/0001209191-21-009341#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":13.04,"price_display":"13.04","price_state":"stated","total_value":48900.0,"total_display":"48,900.00","shares_owned_after":325461.0,"shares_owned_after_display":"325,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider"},{"id":9271387,"accession":"0001209191-21-009339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-009339","line_url":"/filing/0001209191-21-009339#line-2","is_derivative":false,"issuer_cik":"0001556263","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001556263","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5357.0,"shares_display":"5,357","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":46873.75,"total_display":"46,873.75","shares_owned_after":329211.0,"shares_owned_after_display":"329,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2021-02-10","scope":"insider"},{"id":2192993,"accession":"0001209191-20-059113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-059113","line_url":"/filing/0001209191-20-059113#line-2","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5357.0,"shares_display":"5,357","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":46873.75,"total_display":"46,873.75","shares_owned_after":339211.0,"shares_owned_after_display":"339,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-18","scope":"insider"},{"id":9271388,"accession":"0001209191-21-009339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-009339","line_url":"/filing/0001209191-21-009339#line-1","is_derivative":false,"issuer_cik":"0001556263","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001556263","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":633.0,"shares_display":"633","price_per_share":8.98,"price_display":"8.98","price_state":"stated","total_value":5684.34,"total_display":"5,684.34","shares_owned_after":334568.0,"shares_owned_after_display":"334,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2021-02-10","scope":"insider"},{"id":2192988,"accession":"0001209191-20-059113","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-059113","line_url":"/filing/0001209191-20-059113#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":633.0,"shares_display":"633","price_per_share":8.98,"price_display":"8.98","price_state":"stated","total_value":5684.34,"total_display":"5,684.34","shares_owned_after":344568.0,"shares_owned_after_display":"344,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-18","scope":"insider"},{"id":2344802,"accession":"0001209191-20-055334","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-055334","line_url":"/filing/0001209191-20-055334#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5673.0,"shares_display":"5,673","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":49638.75,"total_display":"49,638.75","shares_owned_after":335201.0,"shares_owned_after_display":"335,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-19","filed_date":"2020-10-19","scope":"insider"},{"id":2558419,"accession":"0001209191-20-055059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-055059","line_url":"/filing/0001209191-20-055059#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":317.0,"shares_display":"317","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":2773.75,"total_display":"2,773.75","shares_owned_after":340874.0,"shares_owned_after_display":"340,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-15","filed_date":"2020-10-16","scope":"insider"},{"id":2048653,"accession":"0001209191-20-050618","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-050618","line_url":"/filing/0001209191-20-050618#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5990.0,"shares_display":"5,990","price_per_share":10.39,"price_display":"10.39","price_state":"stated","total_value":62236.1,"total_display":"62,236.10","shares_owned_after":341191.0,"shares_owned_after_display":"341,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-15","filed_date":"2020-09-16","scope":"insider"},{"id":2248073,"accession":"0001209191-20-047501","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047501","line_url":"/filing/0001209191-20-047501#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5990.0,"shares_display":"5,990","price_per_share":12.59,"price_display":"12.59","price_state":"stated","total_value":75414.1,"total_display":"75,414.10","shares_owned_after":347181.0,"shares_owned_after_display":"347,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider"},{"id":3278930,"accession":"0001209191-20-042796","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-042796","line_url":"/filing/0001209191-20-042796#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5990.0,"shares_display":"5,990","price_per_share":11.85,"price_display":"11.85","price_state":"stated","total_value":70981.5,"total_display":"70,981.50","shares_owned_after":353171.0,"shares_owned_after_display":"353,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-15","filed_date":"2020-07-17","scope":"insider"},{"id":3089784,"accession":"0001209191-20-037001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-037001","line_url":"/filing/0001209191-20-037001#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5990.0,"shares_display":"5,990","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":52412.5,"total_display":"52,412.50","shares_owned_after":359161.0,"shares_owned_after_display":"359,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-16","scope":"insider"},{"id":2286341,"accession":"0001209191-20-029763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-029763","line_url":"/filing/0001209191-20-029763#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5990.0,"shares_display":"5,990","price_per_share":9.2224,"price_display":"9.22","price_state":"stated","total_value":55242.176,"total_display":"55,242.18","shares_owned_after":365151.0,"shares_owned_after_display":"365,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-15","filed_date":"2020-05-15","scope":"insider"},{"id":3113171,"accession":"0001209191-20-024775","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-024775","line_url":"/filing/0001209191-20-024775#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23960.0,"shares_display":"23,960","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":209650.0,"total_display":"209,650.00","shares_owned_after":371141.0,"shares_owned_after_display":"371,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-15","filed_date":"2020-04-17","scope":"insider"},{"id":8702831,"accession":"0001209191-19-046516","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-046516","line_url":"/filing/0001209191-19-046516#line-2","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22700.0,"shares_display":"22,700","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":227000.0,"total_display":"227,000.00","shares_owned_after":395101.0,"shares_owned_after_display":"395,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-16","filed_date":"2019-08-19","scope":"insider"},{"id":8702827,"accession":"0001209191-19-046516","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-046516","line_url":"/filing/0001209191-19-046516#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":23000.0,"total_display":"23,000.00","shares_owned_after":417801.0,"shares_owned_after_display":"417,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-15","filed_date":"2019-08-19","scope":"insider"},{"id":4696812,"accession":"0001104659-17-052251","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-052251","line_url":"/filing/0001104659-17-052251#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3282.0,"shares_display":"3,282","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":72204.0,"total_display":"72,204.00","shares_owned_after":420101.0,"shares_owned_after_display":"420,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-14","filed_date":"2017-08-16","scope":"insider"},{"id":4556958,"accession":"0001179110-17-010734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-17-010734","line_url":"/filing/0001179110-17-010734#line-1","is_derivative":false,"issuer_cik":"0001490283","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001490283","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3282.0,"shares_display":"3,282","price_per_share":22.0889,"price_display":"22.09","price_state":"stated","total_value":72495.7698,"total_display":"72,495.77","shares_owned_after":423383.0,"shares_owned_after_display":"423,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-25","filed_date":"2017-07-27","scope":"insider"},{"id":3270707,"accession":"0000930413-12-001600","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-12-001600","line_url":"/filing/0000930413-12-001600#line-1","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":"0001490283","owner_name":"Young Richard A","owner_url":"/insider/0001490283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":6.9211,"price_display":"6.92","price_state":"stated","total_value":13842.2,"total_display":"13,842.20","shares_owned_after":19562.0,"shares_owned_after_display":"19,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-15","filed_date":"2012-03-16","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001736730","name":"Camp4 Therapeutics Corp","url":"/issuer/0001736730","role":"Director","n_filings":2,"first_seen":"2025-09-11","last_seen":"2026-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001556263","name":"Syros Pharmaceuticals, Inc.","url":"/issuer/0001556263","role":"Director","n_filings":16,"first_seen":"2017-07-27","last_seen":"2024-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001850838","name":"Omega Therapeutics, Inc.","url":"/issuer/0001850838","role":"Director","n_filings":6,"first_seen":"2022-09-15","last_seen":"2023-06-05"},{"type":"issuer","type_label":"ISSUER","cik":"0000727510","name":"ENZON PHARMACEUTICALS INC","url":"/issuer/0000727510","role":"Director","n_filings":1,"first_seen":"2012-03-16","last_seen":"2012-03-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001490283","retrieved_at":"2026-08-21T04:21:53+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}